Grants and Contributions:
Title:
Support to COVID-19 Medical Oxygen Response
Agreement Number:
7448366 P011798001
Agreement Value:
$25,000,000.00
Agreement Date:
Mar 9, 2023 - Jul 31, 2024
Description:
This project aims to support Unitaid in advancing equitable and affordable access to medical oxygen for COVID-19 treatments in low- and middle-income countries. The support comes through market interventions to increase the supply and adoption of oxygen innovations and investments in sustainable delivery models. As a result, the project increases the national oxygen systems’ capacity and enables national health systems to treat chronic respiratory conditions such as COVID-19. Project activities include: (1) identifying local and regional liquid and gas suppliers to increase the availability and affordability of medical oxygen for public procurers; (2) supporting sustainable market entry for new medical oxygen suppliers through blended finance approaches; (3) piloting local and regional supply approaches in sub-Saharan Africa; (4) identifying and piloting appropriate, high-impact oxygen innovations and technologies adapted for low-resource settings; and (5) generating and disseminating evidence, including operational guidance.
Organization:
Global Affairs Canada
Expected Results:
The expected outcomes of this project include an increased capacity of oxygen produced and delivered to low- and middle-income countries.
Location:
Geneva, CH
Reference Number:
064-2024-2025-Q2-00491
Agreement Type:
Grant
Report Type:
Grants and Contributions
Recipient Type:
Not-for-profit organization or charity
Additional Information:
Belated reporting
Recipient's Operating Name:
WHO - World Health Organization
Recipient's Legal Name:
WHO - World Health Organization
Program:
International Development Assistance Program
Program Purpose:
The main purpose on the International Development Assistance Program is to reduce poverty for those living in countries where Global Affairs Canada engages in international development.